ELEVANCE HEALTH, INC., DEF 14A filed on 3/28/2025
Proxy Statement (definitive)
v3.25.1
Cover
12 Months Ended
Dec. 31, 2024
Document Information [Line Items]  
Document Type DEF 14A
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name Elevance Health, Inc.
Entity Central Index Key 0001156039
v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Year
Summary Compensation Table Total for Principal Executive Officer (“PEO”)(1)
Compensation Actually Paid to PEO(1)
Average Summary Compensation Table Total for Non-PEO NEOs(1)
Average Compensation Actually Paid to Non-PEO NEOs(1)
Value of Initial Fixed $100 Investment Based On:
Net Income(4) (millions)
Adjusted Net Income(5)
(millions)
Total Shareholder Return(2)
Peer Group Total Shareholder Return(2)(3)
2024$20,471,976 $(3,957,314)$6,325,173 $(256,544)130147$5,971 $7,677 
2023$21,889,039 $16,222,856 $8,918,210 $8,173,085 164143$5,991 $7,838 
2022$20,931,081 $35,256,056 $6,710,732 $10,889,052 176140$5,888 $7,008 
2021$19,348,241 $50,432,186 $6,446,802 $15,664,365 157143$6,149 $6,300 
2020$17,109,952 $28,321,967 $5,388,978 $7,263,535 108113$4,572 $5,984 
       
Company Selected Measure Name Adjusted Net Income        
Named Executive Officers, Footnote The PEO for each of the years presented was Gail Boudreaux and the non-PEO NEOs for 2020, 2021 and 2022 were John Gallina, Peter Haytaian, Gloria McCarthy and Felicia Norwood. The non-PEO NEOs for 2023 were Mark Kaye, Peter Haytaian, Felicia Norwood, Blair Todt and John Gallina.        
Peer Group Issuers, Footnote Company selected peer group is the S&P 500 Health Care Index, the same peer group as reported in Part II, Item 5 in our Form 10-K.        
PEO Total Compensation Amount $ 20,471,976 $ 21,889,039 $ 20,931,081 $ 19,348,241 $ 17,109,952
PEO Actually Paid Compensation Amount $ (3,957,314) 16,222,856 35,256,056 50,432,186 28,321,967
Adjustment To PEO Compensation, Footnote To calculate Compensation Actually Paid for 2024, the following amounts were deducted from and added to the Summary Compensation Table total compensation reported for each of these individuals:
Reconciliation of Summary Compensation Table (“SCT”) Total Compensation to Compensation Actually Paid:
2024
AdjustmentsPEO ($)Average of Non-PEO NEOs ($)
SCT Total$20,471,976 $6,325,173 
Add / (Subtract):
Adjustments for defined benefit and actuarial pension plans(i)
$— $— 
Adjustments for stock and option awards(ii):
SCT amounts$(16,800,021)$(4,850,082)
Year-end fair value for awards granted in the covered year$9,163,524 $2,645,418 
Change in fair value of outstanding unvested awards from prior years$(18,309,520)$(4,567,147)
Vesting date fair value of awards granted and vesting during covered year$— $— 
Change in fair value for prior year awards that vested during the covered year$1,516,727 $190,094 
Fair value of awards forfeited during the covered year$— $— 
Dividends or other earnings paid on awards in the covered year prior to vesting $— $— 
Compensation Actually Paid$(3,957,314)$(256,544)
(i)Represents the change in the actuarial present value of the accumulated benefit under defined benefit and pension plans reported in the Summary Compensation Table for Mr. Kendrick. The value of Mr. Kendrick's benefits under such pension plans decreased by $2,608 in 2024, so, in accordance with the SEC's rules, no amount is shown for 2024. No other NEO is eligible for benefits under a defined benefit or actuarial pension plan.
(ii)Reflects the value of equity-based awards calculated in accordance with the SEC methodology for determining Compensation Actually Paid.
       
Non-PEO NEO Average Total Compensation Amount $ 6,325,173 8,918,210 6,710,732 6,446,802 5,388,978
Non-PEO NEO Average Compensation Actually Paid Amount $ (256,544) 8,173,085 10,889,052 15,664,365 7,263,535
Adjustment to Non-PEO NEO Compensation Footnote To calculate Compensation Actually Paid for 2024, the following amounts were deducted from and added to the Summary Compensation Table total compensation reported for each of these individuals:
Reconciliation of Summary Compensation Table (“SCT”) Total Compensation to Compensation Actually Paid:
2024
AdjustmentsPEO ($)Average of Non-PEO NEOs ($)
SCT Total$20,471,976 $6,325,173 
Add / (Subtract):
Adjustments for defined benefit and actuarial pension plans(i)
$— $— 
Adjustments for stock and option awards(ii):
SCT amounts$(16,800,021)$(4,850,082)
Year-end fair value for awards granted in the covered year$9,163,524 $2,645,418 
Change in fair value of outstanding unvested awards from prior years$(18,309,520)$(4,567,147)
Vesting date fair value of awards granted and vesting during covered year$— $— 
Change in fair value for prior year awards that vested during the covered year$1,516,727 $190,094 
Fair value of awards forfeited during the covered year$— $— 
Dividends or other earnings paid on awards in the covered year prior to vesting $— $— 
Compensation Actually Paid$(3,957,314)$(256,544)
(i)Represents the change in the actuarial present value of the accumulated benefit under defined benefit and pension plans reported in the Summary Compensation Table for Mr. Kendrick. The value of Mr. Kendrick's benefits under such pension plans decreased by $2,608 in 2024, so, in accordance with the SEC's rules, no amount is shown for 2024. No other NEO is eligible for benefits under a defined benefit or actuarial pension plan.
(ii)Reflects the value of equity-based awards calculated in accordance with the SEC methodology for determining Compensation Actually Paid.
       
Compensation Actually Paid vs. Total Shareholder Return
As shown in the following charts, Net Income and Adjusted Net Income have generally increased or remained approximately flat year-over-year since 2020, while the PEO and other NEOs’ Compensation Actually Paid has varied significantly each year. This is primarily due to the significant emphasis we place on equity-based compensation, which is sensitive to changes in our stock price and is more closely aligned with our Total Shareholder Return.
3848290705954 3848290705976
       
Compensation Actually Paid vs. Net Income
As shown in the following charts, Net Income and Adjusted Net Income have generally increased or remained approximately flat year-over-year since 2020, while the PEO and other NEOs’ Compensation Actually Paid has varied significantly each year. This is primarily due to the significant emphasis we place on equity-based compensation, which is sensitive to changes in our stock price and is more closely aligned with our Total Shareholder Return.
3848290705954 3848290705976
       
Tabular List, Table
Most Important Measures for Determining NEO Pay
Adjusted Net IncomeOperating Revenue
Adjusted Net Income GrowthTotal Revenue Growth
       
Total Shareholder Return Amount $ 130 164 176 157 108
Peer Group Total Shareholder Return Amount 147 143 140 143 113
Net Income (Loss) $ 5,971,000,000 $ 5,991,000,000 $ 5,888,000,000 $ 6,149,000,000 $ 4,572,000,000
Company Selected Measure Amount 7,677,000,000 7,838,000,000 7,008,000,000 6,300,000,000 5,984,000,000
PEO Name Gail Boudreaux        
Additional 402(v) Disclosure
The fair values of stock options granted as of the end of 2024 and the year-over-year changes in the fair values of stock options outstanding at the end of, or that vested during, 2024 were calculated using a binomial lattice valuation model, as further described in Note 15, “Capital Stock,” of the Notes to our Consolidated Financial Statements included in Part II, Item 8 of our Form 10-K. The following ranges of assumptions were used to estimate these fair values:
Calendar YearRisk-Free Interest RateVolatility FactorDividend Yield (Annual)
20243.74 - 4.56%29 - 32%1.3 - 1.8%
The fair value of PSUs that vested during 2024 was calculated using the actual performance results of 162.9% as described in the Compensation Discussion & Analysis in the 2024 Proxy Statement.
The fair value of PSUs that will vest during 2025 was calculated using the actual performance results of 95.1% as described in the Compensation Discussion & Analysis in this Proxy Statement.
The fair value of in-flight PSUs was calculated based on the probable performance as determined at the end of the applicable covered year, which is forecasted to be below the target level of performance.
Based upon an initial investment of $100 on December 31, 2019 with dividends reinvested.Our 2021 and 2022 Net Income was recast in 2023 to include the impact of the Accounting Standards Update 2018-12 Adoption. Therefore, the 2021 and 2022 Net Income reported in these disclosures has been adjusted to reflect the recast amounts.Our Company-selected measure is “Adjusted Net Income," calculated as GAAP Shareholders' Net Income, as adjusted for those items set forth in Annex A to this Proxy Statement, and further adjusted for those items that the Committee believes distort the view of management performance and that, if not adjusted, might misalign management incentives under the AIP. For 2024, these additional adjustments included a $17.3 million decrease related to 2024 acquisitions. For 2023, these additional adjustments included a $29.3 million net decrease to exclude 2023 acquisitions and other non-material administrative adjustments. For 2022, these additional adjustments included a $131.0 million increase to exclude the impact of the Accounting Standards Update 2018-12 Adoption and a $50.8 million net decrease to exclude 2022 acquisitions and other non-material administrative adjustments. For 2021, these additional adjustments included a $54.0 million decrease to exclude the impact of the Accounting Standards 2018-12 Adoption and a $111.0 million net decrease to exclude 2021 acquisitions and other non-material administrative adjustments. For 2020, these additional adjustments included a $267.3 million increase related to our response to the COVID-19 pandemic.
       
Measure:: 1          
Pay vs Performance Disclosure          
Name Adjusted Net Income        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted Net Income Growth        
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (16,800,021)        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 9,163,524        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (18,309,520)        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,516,727        
PEO | Equity Awards Granted During the Year, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Equity Awards that Failed to Meet Vesting Conditions [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Equity Awards, Value of Dividends and Other Earnings Paid Adjustment [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,608)        
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (4,850,082)        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 2,645,418        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (4,567,147)        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 190,094        
Non-PEO NEO | Equity Awards Granted During the Year, Vested [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Equity Awards that Failed to Meet Vesting Conditions [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Equity Awards, Value of Dividends and Other Earnings Paid Adjustment [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0        
v3.25.1
Award Timing Disclosure
12 Months Ended
Dec. 31, 2024
Mar. 01, 2024
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]    
Award Timing MNPI Disclosure
Our annual equity grant is approved by the Committee and has been made on the first business day of March each year since 2006, unless otherwise specified by our Board or the Committee. The Committee has delegated authority to management to grant promotional, new hire and retention grants during the remainder of the year as follows:
No grants may be made to the CEO or other executive officers without Committee approval;
Grants are to be dated as of the first business day of the month concurrent with or following the promotion date, hire date or date that a retention grant was approved; and
Management reports off-cycle delegated grant activity at each regularly scheduled Committee meeting.
Neither the Committee nor management grants equity awards in anticipation of the release of material nonpublic information, or otherwise takes material nonpublic information into account when determining the terms of equity awards, and we do not time the release of material nonpublic information based on equity award grant dates.
We made our annual equity grant on March 1, 2024, in accordance with our standard practice, and filed a Current Report on Form 8-K on March 4, 2024 in connection with our participation at an investor conference. As described on page 52, the annual equity grant is made up of a combination of PSUs, stock options and RSUs, with stock options weighted at 25% of the annual award value.
NameGrant DateNumber of securities underlying the awardExercise price of the award ($/Sh)Grant date fair value of the awardPercentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following disclosure of material nonpublic information
Gail Boudreaux3/1/202432,480$499.11$4,199,989-0.15 %
Mark Kaye3/1/202410,633$499.11$1,374,953-0.15 %
Peter Haytaian3/1/20249,280$499.11$1,199,997-0.15 %
Felicia Norwood3/1/20249,280$499.11$1,199,997-0.15 %
Morgan Kendrick 3/1/20248,312$499.11$1,074,825-0.15 %
 
Award Timing Method
Our annual equity grant is approved by the Committee and has been made on the first business day of March each year since 2006, unless otherwise specified by our Board or the Committee. The Committee has delegated authority to management to grant promotional, new hire and retention grants during the remainder of the year as follows:
No grants may be made to the CEO or other executive officers without Committee approval;
Grants are to be dated as of the first business day of the month concurrent with or following the promotion date, hire date or date that a retention grant was approved; and
Management reports off-cycle delegated grant activity at each regularly scheduled Committee meeting.
 
Award Timing Predetermined true  
Award Timing MNPI Considered true  
Award Timing, How MNPI Considered
Neither the Committee nor management grants equity awards in anticipation of the release of material nonpublic information, or otherwise takes material nonpublic information into account when determining the terms of equity awards, and we do not time the release of material nonpublic information based on equity award grant dates.
 
MNPI Disclosure Timed for Compensation Value false  
Awards Close in Time to MNPI Disclosures, Table
NameGrant DateNumber of securities underlying the awardExercise price of the award ($/Sh)Grant date fair value of the awardPercentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following disclosure of material nonpublic information
Gail Boudreaux3/1/202432,480$499.11$4,199,989-0.15 %
Mark Kaye3/1/202410,633$499.11$1,374,953-0.15 %
Peter Haytaian3/1/20249,280$499.11$1,199,997-0.15 %
Felicia Norwood3/1/20249,280$499.11$1,199,997-0.15 %
Morgan Kendrick 3/1/20248,312$499.11$1,074,825-0.15 %
 
Boudreaux [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Gail Boudreaux
Underlying Securities | shares   32,480
Exercise Price | $ / shares   $ 499.11
Fair Value as of Grant Date | $   $ 4,199,989
Underlying Security Market Price Change   (0.0015)
Kaye [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Mark Kaye
Underlying Securities | shares   10,633
Exercise Price | $ / shares   $ 499.11
Fair Value as of Grant Date | $   $ 1,374,953
Underlying Security Market Price Change   (0.0015)
Haytaian [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Peter Haytaian
Underlying Securities | shares   9,280
Exercise Price | $ / shares   $ 499.11
Fair Value as of Grant Date | $   $ 1,199,997
Underlying Security Market Price Change   (0.0015)
Norwood [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Felicia Norwood
Underlying Securities | shares   9,280
Exercise Price | $ / shares   $ 499.11
Fair Value as of Grant Date | $   $ 1,199,997
Underlying Security Market Price Change   (0.0015)
Kendrick [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Morgan Kendrick
Underlying Securities | shares   8,312
Exercise Price | $ / shares   $ 499.11
Fair Value as of Grant Date | $   $ 1,074,825
Underlying Security Market Price Change   (0.0015)
v3.25.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true